Uterine sarcomas

References

• Gaducci A., Landoni F., Sartori E., et al. Uterine leiomyosarcoma: Analysis of treatment failures and survival. Gynecol Oncol 1996; 62: 25–32
   PubMed Web of Science ®Google Scholar
• Gadducci A., Sartori E., Landoni F., et al. Endometrial stromal sarcoma: Analysis of treatment failures and survival. Gynecol Oncol 1996; 63: 247–53
   PubMed Web of Science ®Google Scholar
• Harlow B. L., Weiss N. S., Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986; 76: 399–402
   PubMed Web of Science ®Google Scholar
• Major F. J., Blessing J. A., Silverger S. G., et al. Prognostic factors in early‐stage uterine sarcoma: A Gynaecologic Oncology Group study. Cancer 1993; 71: 1702–9
   PubMed Web of Science ®Google Scholar
• Rovirosa A., Ordi J., Ascaso C., et al. Prognostic factors in uterine sarcomas: A 21‐year retrospective study at the Clinic and Provincial Hospital of Barcelona. Med Clin (Barc) 1998; 111: 172–6
   PubMed Web of Science ®Google Scholar
• Yoonessi M. Endometrial stromal sarcomas. Cancer 1997; 40: 898–906
   Web of Science ®Google Scholar
• Wickerham D. L., Fisher B., Wolmark N., et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002; 20: 2758–60
   PubMed Web of Science ®Google Scholar
• Tavassoli F. A., Devilee P. Tumors of the Breast and Female Genital Tract. Pathology and Genetics. World Health Organization Classification of Tumors. IARC, Lyon 2003
   Google Scholar
• McCluggage W. G. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002; 12: 764–7
   PubMed Web of Science ®Google Scholar
• Beer T. W., Buchanan R., Buckley C. H. Uterine stromal sarcoma following tamoxifen treatment. J Clin Pathol 1995; 48: 596
   PubMed Web of Science ®Google Scholar
• Eddy G. L., Mazur M. T. Endolymphatic stromal myosis associated with tamoxifen use. Gynecol Oncol 1997; 64: 262–4
   PubMed Web of Science ®Google Scholar
• Fisher B., Constantino J. P., Redmon C. K., Fisher E. R., Wickerham L., Cronin W. M. Endometrial cancer in tamoxifen‐treated breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project (NSABP) B‐24. J Natl Cancer Inst 1994; 86: 527–37
   PubMed Web of Science ®Google Scholar
• Gillett D. Leiomyosarcoma of the uterus in a woman taking adjuvant tamoxifen therapy. Med J Aust 1995; 163: 160–1
   PubMed Web of Science ®Google Scholar
• Kennedy M. M., Baigrie C. F., Manek S. Tamoxifen and the endometrium: Review of 102 cases and comparison with HRT‐related and non‐HRT‐related endometrial pathology. Int J Gynecol Pathol 1999; 18: 130–7
   PubMed Web of Science ®Google Scholar
• McCluggage W. G., Varma M., Weir P., Bharucha H. Uterine leiomyosarcoma in patient receiving tamoxifen therapy. Acta Obstet Gynecol Scand 1996; 75: 593–5
   PubMed Web of Science ®Google Scholar
• Okada D. H., Rowland J. B., Petrovic L. M. Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapy. Gynecol Oncol 1999; 75: 509–13
   PubMed Web of Science ®Google Scholar
• Pang L. C. Endometrial stromal sarcoma with sex cord‐like differentiation associated with tamoxifen therapy. South Med J 1998; 91: 592–4
   PubMed Web of Science ®Google Scholar
• Silva E. G., Tornos C. S., Follen‐Mitchell M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: The effects of tamoxifen. Int J Gynecol Pathol 1994; 13: 248–58
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. An overview of the randomized trials. Lancet 1998; 351: 1451–67
   PubMed Web of Science ®Google Scholar
• Fisher B., Dignam J., Wolmark N., et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B‐24 randomized controlled trial. Lancet 1999; 353: 1993–2000
   PubMed Web of Science ®Google Scholar
• Fisher B., Constantino J. P., Wickerham D. L., et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P‐1 study. J Natl Cancer Inst 1998; 90: 1371–88
   PubMed Web of Science ®Google Scholar
• Kloos I., Delaloge S., Pautier P., et al. Tamoxifen‐related uterine carcinosarcomas occur under/after prolonged treatment: Report of five cases and review of the literature. Int J Gynecol Cancer 2002; 12: 496–500
   PubMed Web of Science ®Google Scholar
• Yildirim Y., Inal M. M., Sanci M., et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: Report of four cases. Int J Gynecol Cancer 2005; 15: 1239–42
   PubMed Web of Science ®Google Scholar
• Madison T., Scottenfeld O., Baker V. Cancer of the corpus uteri in white and black women in Michigan 1985–1994 an analysis of trends in incidence and mortality and their relation to histologic subtype and stage. Cancer 1998; 83: 1546–54
   PubMed Web of Science ®Google Scholar
• De Fusco P. A., Gaffey T. A., Malkasian G. D., Jr., Long H. J., Cha S. S. Endometrial stromal sarcoma: Review of Mayo Clinic experience, 1945–1980. Gynecol Oncol 1989; 35: 8–14
   PubMed Web of Science ®Google Scholar
• Chang K. L., Crabtree G. S., Lim‐Tan S. K., Kempson R. L., Hendrickson M. R. Primary uterine endometrial stromal sarcoma: A clinicopathology study of 117 cases. Am J Surg Pathol 1990; 14: 415–38
   PubMed Web of Science ®Google Scholar
• McCluggage W. G., Date A., Bharucha H., Toner P. G. Endometrial stromal sarcoma with sex cord‐like areas and focal rhabdoid differentiation. Histopathology 1996; 29: 369–74
   PubMed Web of Science ®Google Scholar
• McCluggage W. G., Sumathi V. P., Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001; 39: 273–8
   PubMed Web of Science ®Google Scholar
• Nucci M. R., O'Connell J. T., Huettner P. C., et al. h‐Caldesmon effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 2001; 25: 455–63
   PubMed Web of Science ®Google Scholar
• Baker R. J., Hildebrandt R. H., Rouse R. V., et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex‐cord‐like elements. Hum Pathol 1999; 30: 671–9
   PubMed Web of Science ®Google Scholar
• Moinfar F., Regitnig P., Tabrizi A. D., Denk H., Tavassoli F. A. Expression of androgen receptors in benign and malignant endometrial stromal neoplasms. Virchows Arch 2004; 444: 410–4
   PubMed Web of Science ®Google Scholar
• Moinfar F., Kamerer‐Gogg M., Sommersacher A., et al. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER1): potential basis for a new therapeutic approach. Am J Surg Pathol 2005; 29: 485–9
   PubMed Web of Science ®Google Scholar
• Blom R., Malmstrom H., Guerrieri C. Endometrial stromal sarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm‐2 analysis of 17 cases. Int J Gynecol Cancer 1999; 9: 98–104
   PubMed Web of Science ®Google Scholar
• Hitchcock C. L., Norris H. J. Flow cytometric analysis of endometrial stromal sarcoma. Am J Clin Pathol 1992; 97: 267–71
   PubMed Web of Science ®Google Scholar
• Amant F., Moreman P., Cadron I., Hagemeijer A., Vergote I., Debiec‐Rychter M. Endometrial stromal sarcoma with a sole t(X;17) chromosome change: Report of a case and review of the literature. Gynecol Oncol 2003; 88: 459–62
   PubMed Web of Science ®Google Scholar
• Dal Cin P., Aly M. S., De Wever I., Moreman P., Van Den Berghe H. Endometrial stromal sarcoma t(7;17)(p15‐21;q12‐21) is a non‐random chromosome change. Cancer Genet Cytogenet 1992; 63: 43–6
   PubMedGoogle Scholar
• Hrynchak M., Horsman D., Salski C., Berean K., Benedet J. L. Complex karyotypic alterations in an endometrial stromal sarcoma. Cancer Genet Cytogenet 1994; 77: 45–9
   PubMedGoogle Scholar
• Sonobe h., Iwata J., Furihata M., Ohtsuki Y., Taguchi T., Shimizu K. Endometrial stromal sarcoma with clonal complex chromosome abnormalities. Report of a case and review of the literature. Cancer Genet Cytogenet 1999; 112: 34–7
   PubMedGoogle Scholar
• Halbwedl I., Ulmann R., Kremser‐ML. Chromosomal alterations in low‐grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. Gynecol Oncol 2005; 97: 582–7
   PubMed Web of Science ®Google Scholar
• Koontz J. I., Soreng A. L., Nucci M., Kuo F. C., Pauwels P., van Den Berghe H. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Sci USA 2001; 98: 6348–53
   PubMed Web of Science ®Google Scholar
• Micci F., Walter C. U., Teixeira M. R., Panagopoulos I., Bjerkehagen B., Saeter G. Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: Nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet 2003; 144: 119–24
   PubMedGoogle Scholar
• Hrzenjak A., Moinfar F., Tavassoli F. A., et al. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas. Molecular analysis by reverse transcriptase‐polymerase chain reaction optimized for paraffin‐embedded tissue. J Mol Diagn 2005; 7: 388–95
   PubMed Web of Science ®Google Scholar
• Gunawan B., Shulten H‐J., Fuzesi L. Identification of a BAC clone overlapping the t(6p12.3) breakpoint in the cell line ESS‐1 derived from and endometrial stromal sarcoma. Cancer Genet Cytogenet 2003; 147: 84–6
   PubMedGoogle Scholar
• Moinfar F., Kremser M. L., Man Y. G., Zatloukal K., Tavassoli F. A., Denk H. Allelic imbalances in endometrial stromal neoplasms: frequent genetic alterations in the nontumerous normal‐appearing endometrial and myometrial tissues. Gynecol Oncol 2004; 95: 662–71
   PubMed Web of Science ®Google Scholar
• Hrzenjak A., Tipple M., Kremser M. L., et al. Inverse correlation of secreted frizzled‐related protein 4 and beta‐catenin expression in endometrial stromal sarcomas. J Pathol 2004; 204: 19–27
   PubMed Web of Science ®Google Scholar
• Bafico A., Grazit A., Pramila T., Finch P. W., Yaniv A., Aoronson S. A. Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signalling. J Biol Chem 1999; 274: 16180–7
   PubMed Web of Science ®Google Scholar
• Wong S. C. C., Lo S. F. E., Lee K. C., Yam J. W. P., Chan J. K. C., Hsiao W. L. W. Expression of frizzled‐related protein and Wnt‐signalling molecules in invasive human breast tumors. J Pathol 2002; 196: 145–53
   PubMed Web of Science ®Google Scholar
• Itoh T., Mochizuki M., Kumazaki S., Ishihara T., Fukayama M. Cystic pulmonary metastases of endometrial stromal sarcoma of the uterus, mimicking lymphangiomyomatosis: a case report with immunohistochemistry of HMB45. Pathol Int 1997; 47: 725–9
   PubMed Web of Science ®Google Scholar
• Lissoni A., Cormio G., Bonazzi C., et al. Fertility‐sparing surgery in uterine leiomyosarcoma. Gynecol Oncol 1998; 70: 348–50
   PubMed Web of Science ®Google Scholar
• Piver M. S., Rutledge F. N., Copeland L., Webster K., Blumenson L., Suh O. Uterine endolymphatic stromal myosis: A collaborative study. Obstet Gynecol 1984; 64: 173–8
   PubMed Web of Science ®Google Scholar
• Keen C. E., Philip G. Progestogen‐induced regression in low‐grade endometrial stromal sarcoma. Case report and literature review. Br J Obstet Gynaecol 1989; 96: 1435–9
   PubMedGoogle Scholar
• Nordal R. N., Kjorstad K. E., Stenwig A. E., Trope C. G. Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985. Int J Gynecol Cancer 1993; 3: 110–5
   PubMed Web of Science ®Google Scholar
• Evans H. L. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982; 50: 2170–82
   PubMed Web of Science ®Google Scholar
• Bodner K., Bodner‐Adler B., Obermair A., et al. Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients. Gynecol Oncol 2001; 81: 160–5
   PubMed Web of Science ®Google Scholar
• de Nictolis M., Montironi R., Tommasoni S., Maggiera G. High‐grade endometrial stromal sarcoma: Clinicopathologic and immunohistochemical study of a case. Pathologica 1994; 86: 217–21
   PubMedGoogle Scholar
• Leibsohn D., d'Ablaing G., Mishrll D. R., Jr., Schlaerth J. B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 1990; 162: 968–74
   PubMed Web of Science ®Google Scholar
• Christopherson W. M., Williamson E. O., Gray L. A. Leiomyosarcoma of the uterus. Cancer 1972; 29: 1512–7
   PubMed Web of Science ®Google Scholar
• Covens A. L., Nisker J. A., Chapman W. B., Allen H. H. Uterine sarcoma: An analysis of 74 cases. Am J Obstet Gynecol 1987; 156: 370–4
   PubMed Web of Science ®Google Scholar
• Hart W. R., Craig J. R. Rhabdomyosarcomas of the uterus. Am J Clin Pathol 1978; 70: 217–23
   PubMed Web of Science ®Google Scholar
• Schwartz L. B., Diamond M. P., Schwartz P. E. Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 1993; 168: 180–3
   PubMed Web of Science ®Google Scholar
• Wheelock J. B., Krebs H. B., Schneider V., Goplerud D. R. Uterine sarcoma: Analysis of prognostic variables in 71 cases. Am J Obstet Gynecol 1985; 151: 1016–22
   PubMed Web of Science ®Google Scholar
• Lee W‐Y., Tzeng C‐C., Chou C‐Y. Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone‐releasing Hormone agonist. Gynecol Oncol 1994; 52: 74–9
   PubMed Web of Science ®Google Scholar
• Parker W. H., Fu Y. S., Berek J. S. Uterine sarcomas in patients operated on for presumed leiomyomas and rapidly growing leiomyomas. Obstet Gynecol 1994; 83: 414–8
   PubMed Web of Science ®Google Scholar
• Barter J. F., Smith E. B., Szpak C. A., Hinshaw W., Clarke‐Pearson D. L., Creasman W. T. Leiomyosarcoma of the uterus: Clinocopathologic study of 21 cases. Gynecol Oncol 1985; 21: 220–7
   PubMed Web of Science ®Google Scholar
• Watanabe K., Hiraki H., Ohishi M., et al. Uterine leiomyosarcoma with osteoclast‐like giant cells: histopathological and cytological observations. Pathol Int 1996; 46: 656–60
   PubMed Web of Science ®Google Scholar
• Aru A., Norup P., Bjerregaard B., Andreasson B., Horn T. Osteoclast‐like giant cells in leiomyomatous tumors of the uterus. A case report and review of the literature. Acta Obstet Gynecol Scand 2001; 80: 371–4
   PubMed Web of Science ®Google Scholar
• Bell S. W., Kempson R. L., Hendrickson M. R. Problematic uterine smooth muscle neoplasms: A clinicopathologic study of 21 cases. Am J Surg Pathol 1994; 18: 576–82
   PubMed Web of Science ®Google Scholar
• Major F. J., Blessing J. A., Silverber S. G., et al. Prognostic factors in early‐stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer 1993; 71((Suppl))1702–9
   PubMed Web of Science ®Google Scholar
• Zaloudek C., Hendrickson M. R. Mesenchymal tumors of the uterus. Blaustein's Pathology of the Genital Tract, R Kurman. Springer, New York 2001; 580, 5th ed
   Google Scholar
• Atkins K., Bell S., Kewmpson R., Hendrickson M. Epithelioid smooth muscle neoplasms of the uterus. Mod Pathol 2001; 14: 132A
   Web of Science ®Google Scholar
• Karpuz V., Joris F., Letovanec N., Branchmanski F., Kapanci Y. Metastizing low‐grade clear cell leiomyosaracoma of the uterus. Pathol Int 1998; 48: 82–5
   PubMed Web of Science ®Google Scholar
• Prayson R. A., Hart W. R. Mitotically active leiomyomas of the uterus. Am J Clin Pathol 1992; 97: 14–20
   PubMed Web of Science ®Google Scholar
• Kurman R. J., Norris H. J. Mesenchymal tumors of the uterus. VI Epithelioid smooth muscle tumors including leiomyoblastoma and clear cell leiomyoma: a clinical and pathological analysis of 26 cases. Cancer 1976; 37: 1853–6
   PubMed Web of Science ®Google Scholar
• Atkins K., Bell S., Kempson R., Hendrickson M. Myxoid smooth muscle neoplasms of the uterus. Mod Pathol 2001; 14: 132A
   Web of Science ®Google Scholar
• Chen K. T. Myxoid leiomyosarcoma of the uterus. Int J Gynecol Pathol 1984; 3: 389–92
   PubMed Web of Science ®Google Scholar
• King M. E., Dickersin G. R., Scully R. E. Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 1982; 6: 589–98
   PubMed Web of Science ®Google Scholar
• Peacock G., Archer S. Myxoid leiomyosaracoma of the uterus: case report and review of the literature. Am J Obstet Gynecol 1989; 160: 1515–8
   PubMed Web of Science ®Google Scholar
• Kunzel K. E., Mills N. Z., Muderspach L. I., d'Ablaing G., III. Myxoid leiomyosarcoma of the uterus. Gynecol Oncol 1993; 48: 277–80
   PubMed Web of Science ®Google Scholar
• Schneider D., Halperin R., Segal M., Maymon R., Bukovsky I. Myxoid leiomyosarcoma of the uterus with unusual malignant histologic pattern: a case report. Gynecol Oncol 1995; 59: 156–8
   PubMed Web of Science ®Google Scholar
• Darby A. J., Papadaki L., Beilby J. O. An unusual leiomyosarcoma of the uterus containing osteoclast‐like giant cells. Cancer 1975; 36: 495–504
   PubMed Web of Science ®Google Scholar
• Evans N. Malignant myomata and related tumors of the uterus. Surg Gynecol Obstet 1920; 30: 225–39
   Google Scholar
• Marshall R. J., Braye S. G., Jones D. B. Leiomyosarcoma of the uterus with giant cells resembling osteoclasts. Int J Gynecol Pathol 1986; 5: 260–8
   PubMed Web of Science ®Google Scholar
• Patai K., Illyes G., Varbiro S., Gidai J., Kosa L., Vajo Z. Uterine leiomyosarcoma with osteoclast like giant cells and long standing systemic symptoms. Gynecol Oncol 2006; 102: 403–5
   PubMed Web of Science ®Google Scholar
• Pilon V. A., Parikh N., Maccera J. Malignant osteoclast‐like giant cell tumor associated with a uterine leiomyosarcoma. Gynecol Oncol 1986; 23: 381–6
   PubMed Web of Science ®Google Scholar
• Chen K. T. K. Leiomyosarcoma with osteoclast‐like giant cells (letter). Am J Surg Pathol 1995; 19: 487–8
   PubMed Web of Science ®Google Scholar
• Sieinski W. Malignant giant cell tumor associated with leiomyosarcoma of the uterus. Cancer 1990; 65: 1838–42
   PubMed Web of Science ®Google Scholar
• Bodner K., Bodner‐Adler B., Kimberger O., et al. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathologic parameters. Anticancer Res 2003; 23: 729–32
   PubMed Web of Science ®Google Scholar
• Leitao M. M., Soslow R. A., Nonaka D., et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in leiomyomata and leiomyosarcoma. Cancer 2004; 101: 11455–62
   Web of Science ®Google Scholar
• Sutton G. P., Stehman F. B., Michael H., et al. Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol 1986; 68: 709–15
   PubMed Web of Science ®Google Scholar
• Poncelet C., Walker F., Madelenat P., et al. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: A possible diagnostic tool for the diagnosis of leiomyosarcoma. Hum Pathol 2001; 32: 1190–6
   PubMed Web of Science ®Google Scholar
• Sandberg A. A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Leiomyosarcoma. Cancer Genet Cytogenet 2005; 161: 1–19
   PubMedGoogle Scholar
• Packenham J. P., du Manoir S., Schrock E., et al. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog 1997; 19: 273–9
   PubMed Web of Science ®Google Scholar
• Quade B. J., Pinto A. P., Howarad D. R., et al. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. Am J Pathol 1999; 154: 949–50
   Web of Science ®Google Scholar
• Quade B. J., Wang T. Y., Sornberger K., et al. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer 2005; 40: 97–108
   Web of Science ®Google Scholar
• Esposito N. N., Hunt J. L., Bakker A., Jones M. W. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors. Am J Surg Pathol 2006; 3: 97–103
   Web of Science ®Google Scholar
• Quade B. J. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 1995; 7: 35–42
   PubMed Web of Science ®Google Scholar
• Rose P. G., Piver M. S., Tsukada Y., Lau T. Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer 1989; 63: 935–8
   PubMed Web of Science ®Google Scholar
• Fleming W. P., Peters W. A., Kumar N. B., Morley G. W. Autopsy findings in patients with uterine sarcoma. Gynecol Oncol 1984; 19: 168–72
   PubMed Web of Science ®Google Scholar
• Goff B. A., Rice L. W., Fleischhacker D., et al. Uterine leiomyosarcoma and endometrial stroma sarcoma: Lymph node metastases and sites of recurrence. Gynecol Oncol 1993; 50: 105–9
   PubMed Web of Science ®Google Scholar
• Evans H. L., Chawla S. P., Simpson C., Finn K. P. Smooth muscle neoplasm of the uterus other than ordinary leiomyoma: A study of 46 cases, with emphasis on diagnostic criteria and prognostic factor. Cancer 1988; 62: 2239–47
   PubMed Web of Science ®Google Scholar
• Vardi J. R., Tovell H. M. M. Leiomyosarcoma of the uterus: A clinicopathologic study. Obstet Gynecol 1980; 56: 428–34
   PubMed Web of Science ®Google Scholar
• Blom R., Guerrieri C., Stal O., Malmstrom H., Simonsen E. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm‐2 analysis of 49 cases. Gynecol Oncol 1998; 68: 54–61
   PubMed Web of Science ®Google Scholar
• Kahanpaa K. V., Wahlstrom T., Grohn P., et al. Sarcomas of the uterus: A clinicopathologic study of 119 patients. Obstet Gynecol 1986; 67: 417–24
   PubMed Web of Science ®Google Scholar
• Marchese M. J., Liskow A. S., Crum C. P., et al. Uterine sarcomas: A clinicopathologic study, 1965–1981. Gynecol Oncol 1984; 18: 299–312
   PubMed Web of Science ®Google Scholar
• Larson B., Silfversward C., Nilsson B., Petterson F. Prognostic factors in uterine leiomyosarcoma: A clinicopathologic study of 143 cases. The Radiumhemmet series, 1936–1981. Acta Oncol 1990; 29: 185–91
   PubMed Web of Science ®Google Scholar
• Nordal R. R., Kristensen G. B., Kaern J., et al. The prognostic significance of stage, tumor size, cellular atypia and DAN ploidy in uterine leiomyosarcoma. Acta Oncol 1995; 34: 797–802
   PubMed Web of Science ®Google Scholar
• Hart W. R., Billman JK J. r. A reassessment of uterine neoplasm originally diagnosed as leiomyosarcomas. Cancer 1978; 41: 1902–10
   PubMed Web of Science ®Google Scholar
• Mayerhofer K., Obermair A., Windbichler G., et al. Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196–201
   PubMed Web of Science ®Google Scholar
• Pautier P., Genmestie C., Rey A., et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 2000; 88: 1425–31
   PubMed Web of Science ®Google Scholar
• Layfield L. J., Liu K., Dodge R., Barsky S. H. Uterine smooth muscle tumor. Utility of classification by proliferation, ploidy and prognostic markers versus traditional histopathology. Arch Pathol Lab Med 2000; 124: 221–7
   PubMed Web of Science ®Google Scholar
• Olah K. S., Dunn J. A., Gee H. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynecol 1992; 99: 590–4
   PubMedGoogle Scholar
• Levenback C., Rubin S. C., McCormick P. M., et al. Resection of pulmonary metastases from uterine sarcomas. Gynecol Oncol 1992; 45: 202–5
   PubMed Web of Science ®Google Scholar
• Kanejekal S., Chambers A., Fung M. F., Verma S. Systemic therapy for advanced uterine sarcoma: a systemic review of the literature. Gynecol Oncol 2005; 97: 624–37
   PubMed Web of Science ®Google Scholar
• Berchuck A., Rubin S. C., Hoskins W. J., et al. Treatment of uterine leiomyosarcoma. Obstet Gynecol 1988; 71: 845–50
   PubMed Web of Science ®Google Scholar
• Hannigan E. V., Gomez L. G. Uterine leiomyosarcoma: A review of prognostic clinical and pathologic features. Am J Obstet Gynecol 1979; 134: 557–64
   PubMed Web of Science ®Google Scholar
• Holcomb K., Francis M., Ruiz J., Abulafia O., Matthews R. P., Lee Y. C. Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal woman with elevated serum CA125. Gynecol Oncol 1999; 74: 499–501
   PubMed Web of Science ®Google Scholar
• Kulka E. W., Douglas G. W. Rhabdomyosarcoma of the corpus uteri: Report of a case, associated with adenocarcinoma of the cervix, with review of the literature. Cancer 1952; 5: 727–36
   PubMed Web of Science ®Google Scholar
• McCluggage W. G., Lioe T. F., McClelland H. R., Lamki H. Rhabdomyosarcoma of the uterus: Report of two cases, including one of the spindle cell variant. Int J Gynecol Cancer 2002; 12: 128–32
   PubMed Web of Science ®Google Scholar
• Ordi J., Stamatakos M. D., Tavassoli F. A. Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 1997; 16: 369–77
   PubMed Web of Science ®Google Scholar
• Podczaski E., Sees J., Kaminski P., et al. Rhabdomyosarcoma of the uterus in a postmenopausal patient. Gynecol Oncol 1990; 37: 439–42
   PubMed Web of Science ®Google Scholar
• Borka K., Patai K., Rendek A., Sobel G., Paulin F. Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal patient. Pathol Oncol Res 2006; 12: 102–4
   PubMed Web of Science ®Google Scholar
• Chiarle R., Godio L., Fusi D., et al. Pure alveolar rhabdomyosarcoma of the corpus uteri: description of a case with serum level of CA‐125. Gynecol Oncol 1997; 66: 320–3
   PubMed Web of Science ®Google Scholar
• Ng T. Y., Loo K. T., Leung T. W., et al. Alveolar rhabdomyosarcoma of the cervix. Gynecol Oncol 2003; 91: 623–6
   PubMed Web of Science ®Google Scholar
• Ojwang S. B., Rana F., Sayed S., Aruasa W. K. Embryonal rhabdomyosarcoma with uterine inversion: Case report. East Afr Med J 2006; 83: 110–3
   PubMedGoogle Scholar
• Montag T. W., D'Ablaing G., Schlaerth J. B., et al. Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol 1986; 25: 171–94
   PubMed Web of Science ®Google Scholar
• Mendez L. E., Joy S., Angioli R., Estape R., Penalver M. Primary uterine angiosarcoma. Gynecol Oncol 1999; 75: 272–6
   PubMed Web of Science ®Google Scholar
• Schammel D. P., Tavassoli F. A. Uterine angiosarcomas: A morphologic and immunohistochemical study of four cases. Am J Surg Pathol 1998 Feb; 22(2): 246–50
   Web of Science ®Google Scholar
• Karateke A., Gurbuz A., Kabaca C., Alkan A., Kir G., Cetiner H. Uterine liposarcoma in a young woman: A case report. Int J Gynecol Cancer 2005; 15: 1230–4
   PubMed Web of Science ®Google Scholar
• Obafunwa J. O., Uguru V. E. Liposarcoma of the cervix. Trop Geogr Med 1990; 42: 90–1
   PubMedGoogle Scholar
• Bapat K., Brustein S. Uterine sarcoma with liposarcomatous differentiation: Report of a case and review of the literature. Int J Gynaecol Obstet 1989; 28: 71–5
   PubMed Web of Science ®Google Scholar
• Levine P. H., Wei X. J., Gagner J. P., Flax H., Mittal K., Blank S. V. Pleomorphic liposarcoma of the uterus: Case report and literature review. Int J Gynecol Pathol 2003; 22: 407–11
   PubMed Web of Science ®Google Scholar
• Carter E. R., McDonald J. R. Uterine mesodermal mixed tumors. Am J Obstet Gynecol 1960; 80: 368–73
   PubMed Web of Science ®Google Scholar
• Middlebrook L. F., Tennant R. Rhabdomyosarcoma of uterine corpus: Report of 2 cases. Obstet Gynecol 1968; 32: 537–42
   PubMed Web of Science ®Google Scholar
• Lurain A. R., Monroe T. Mixed mesodermal sarcoma of the corpus uteri associated with bilateral thecoma. Am J Obstet Gynecol 1959; 78: 613–7
   PubMed Web of Science ®Google Scholar
• Ober W. B., Tovel H. M. M. Mesenchymal sarcomas of the uterus. Am J Obstet Gynecol 1959; 77: 246–68
   PubMed Web of Science ®Google Scholar
• Edwards D. L., Sterling L. N., Keller R. H., Nolan J. F. Mixed heterologous mesenchymal sarcomas (mixed mesodermal sarcomas) of the uterus: Addition of 7 cases. Am J Obstet Gynecol 1963; 85: 1002–11
   Web of Science ®Google Scholar
• Donkers Kazzaz B. A., Meijering J. H. Rhabdomyosarcoma of the corpus uteri: Report of two cases with review of the literature. Am J Obstet Gynecol 1972; 114: 1025–30
   PubMed Web of Science ®Google Scholar
• Siegal G. P., Taylor III L. L., Nelson K. G., et al. Characterization of a pure heterologous sarcoma of the uterus: Rhabdomyosarcoma of the corpus. Int J Gynecol Pathol 1983; 2: 303–15
   PubMed Web of Science ®Google Scholar
• Lloyd R. V., Hajdu S. I., Knapper W. H. Embryonal rhabdomyosarcoma in adults. Cancer 1983; 51: 557–65
   PubMed Web of Science ®Google Scholar
• Jaworski R. C., Rencoret R. H., Moir D. H. Pleomorphic rhabdomyosarcoma of the uterus: Case report with a review of the literature. Br J Obstet Gynaecol 1984; 91: 1269–73
   PubMedGoogle Scholar
• Scheidt P., Moerman P. H., Vergote I. Rhabdomyosarcoma of the corpus of the uterus: A case report. Eur J Gynaecol Oncol 2000; 21: 371–3
   PubMed Web of Science ®Google Scholar
• Behtash N., Mousavi A., Tehranian A., Khanafshar N., Hanjani P. Embryonal rhabdomyosarcoma of the uterine cervix: Case report and review of the literature. Gynecol Oncol 2003; 91: 452–5
   PubMed Web of Science ®Google Scholar
• Reynolds E. A., Logani S., Moller K., Horowitz I. R. Embryonal rhabdomyosaracoma of the uterus in a postmenopausal woman. Case report and review of the literature. Gynecol Oncol 2006; 103: 736–9
   PubMed Web of Science ®Google Scholar
• Witkin G. B., Askin F. B., Geratz J. D., Reddick R. L. Angiosarcoma of the uterus: a light microscopic, immunohistochemimcal and ultrastructural study. Int J Gynecol Pathol 1987; 6: 176–84
   PubMed Web of Science ®Google Scholar
• Milne D. S., Hinshaw K., Malcom A. J., Hilton P. Primary angiosarcoma of the uterus: A case report. Histopathology 1990; 16: 203–5
   PubMed Web of Science ®Google Scholar
• Quinonez G. E., Paraskevas M. P., Diocee M. S., Lorimer S. M. Angiosarcoma of the uterus: A case report. Am J Obstet Gynecol 1991; 164: 90–2
   PubMed Web of Science ®Google Scholar
• Tallini G., Price F. V., Carcangiiu M. L. Epithelioid angiosarcoma arising in uterine leiomyomas. Am J Clin Pathol 1993; 100: 514–8
   PubMed Web of Science ®Google Scholar
• Drachenberg C. B., Faust F. J., Borkowski A., Papadimitriuo J. C. Epitheliod angiosarcoma of the uterus arising in the leiomyoma with associated ovarian and tubal angiomatosis. Am J Clin Pathol 1994; 102: 388–9
   PubMed Web of Science ®Google Scholar
• Veliath A. J., Hannah P., Ratnakar C., Jayanthi K., Aurora A. L. Primary liposarcoma of the cervix: A case report. Int J Gynaecol Obstet 1978; 16: 79–9
   Google Scholar
• Schmidt C., Doroszewski A. W. Liposarcoma of the uterus. A case report. Geburtshilfe Frrauerheilkd 1996; 56: 262–4
   PubMed Web of Science ®Google Scholar
• Schneebauer J., Brinninger G., Halabi M., Nagi F. Liposarcoma of the uterus. Gynakol Geburtshilfliche Rundsch 1996; 36: 90–1
   PubMedGoogle Scholar
• Takeuchi K., Murata K., Funaki K., Fujita K., Hayakawa Y., Kitazawa S. Liposarcoma of the uterine cervix: case report. Eur J Gynaecol Oncol 2000; 21: 290–1
   PubMed Web of Science ®Google Scholar